The business idea of CombiGene is centered on developing efficient gene therapies for the treatment of challenging diseases that currently lack adequate treatment methods. The company plans to independently manage the preclinical development and initial clinical trials of its candidate drugs, with subsequent development and commercialization done on its own or in collaboration with other partners. Established based on scientific breakthroughs from Lund University and the University of Copenhagen, CombiGene is located at Medicon Village in Lund, Sweden.